Sousa, J M <br/><br/>
Comparison between levels of anti-HBS with a fixed administration dose of HBIG and a combination of HBIG and lamivudine for the prophylaxis of hepatitis B after liver transplantation.  [electronic resource] 

 -  Transplantation proceedings  Mar 2003 
 - 723-4 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0041-1345 
<br/><br/><label>Standard No.: </label>10.1016/s0041-1345(03)00065-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Viral--blood<br/>Antiviral Agents--therapeutic use<br/>Hepatitis B--prevention & control<br/>Hepatitis B Surface Antigens--immunology<br/>Hepatitis B virus--immunology<br/>Humans<br/>Immunoglobulins--therapeutic use<br/>Lamivudine--therapeutic use<br/>Liver Transplantation--adverse effects<br/>Middle Aged<br/>Postoperative Complications--prevention & control<br/>Recurrence<br/>Retrospective Studies